Excerpts

Although not statistically significant, female patients showed a trend toward longer hospitalization (β = 12.14 days, p = 0.078), which may warrant further investigation.

Gestational age ≥37 weeks showed borderline significance (aOR: 1.32, 95% CI: 0.97-1.80, p=0.078).

The analysis revealed that while age, gender, and family history were not statistically significant predictors, a higher educational level (university degree or above) showed a notable trend toward a lower likelihood of reporting psychological barriers (OR: 0.56, 95% CI: 0.30-1.06, p = 0.078).

Multivariable regression indicated that higher educational attainment showed a trend toward a lower likelihood of reporting psychological barriers (OR: 0.56, p = 0.078).

As shown in Table 2 , female gender demonstrated a trend toward significance (10/15, 66.7% vs. 177/312, 56.7%; p = 0.078).

TAPSE/PASP <0.32 showed a numerical trend toward higher mortality compared to the normal ratio (32.1% vs. 15.8%, p=0.0785), but this was not statistically significant, while moderate impairment (0.32-0.419) was comparable to normal level (18.9% vs. 15.8%, p=0.7727).

In contrast, participants treated with placebo+SOC showed an increase in uACR by 159.55% (99.88 μg/mg) with p-value approaching significance (p=0.079), again emphasizing the beneficial outcome when NAC+taurine was supplemented to SOC (Table 2 , Figure 2 ).

Gender also approached significance (p=0.079), with higher failure observed in males (10.3%) relative to females (5.0%).

The DTB parameter was almost significant with P = 0.079.

Although not statistically significant, neonates born via caesarean section showed a trend toward delayed oxygenation compared with those delivered vaginally, with mean pre-ductal times of 9.05 vs. 8.41 minutes, respectively (p = 0.079).

Time from last fraction of brachytherapy to date of neck dissection showed a trend toward statistical significance (HR: 0.907, 95% CI: 0.814-1.011, p=0.079).

68.9%), but this relationship was marginally non-significant (χ2 = 3.08, df = 1, p = 0.08).

Higher-income remained significantly associated with greater risk in the multivariable model when accounting for other factors such as medical comorbidities (adjusted OR 1.35, 95% CI 1.25-1.46, P < 0.001), whereas white race was borderline significant when other factors were accounted for (adjusted OR 3.88, 95% CI 1.06-25.33, P = 0.08).

Regarding pathogen type, gram-negative infections showed a trend towards lower mortality (OR 0.53, 95% CI 0.27-1.04, p=0.08), though not statistically significant.

Wound complications The prevalence of wound complications was not significantly significant; nine studies saw a pooled estimated SMD of 0.49 (95% CI 0.22, 1.10; P = 0.08) (Figure 7 ).

There was a marginally significant difference in perceptions of barriers (p=0.08), with males perceiving slightly more barriers than females.

However, UACR showed a borderline significant effect (p = 0.080).

The analysis may be underpowered to confirm smaller but clinically meaningful differences, particularly for the LBR, where a borderline non-significant trend (p=0.08) was observed.

Reduced prevalence of dementia showed a trend toward independent association with the use of warfarin when an exploratory logistic regression was done (p=0.08) [ 24 ].

While 90-day mortality showed a trend toward higher rates in transfused patients (2.4%, n=41 vs 0.5%, n=354), this difference did not reach statistical significance (p=0.08).

According to the Cochrane analysis, “all studies showed a trend towards a better amputation-free salvage in the SCS group” as low as p=0.08 in the Spincemaille et al. study [ 25 , 27 ].

As displayed in Table 2 , compared to those with their disease in remission, patients with ongoing active disease (progressors) had significantly more stress (p<0.001), low education status (borderline significance of p=0.08), significantly worse functional capacity as per HAQ scores (p<0.001), and more hematological and renal involvements (p<0.001).

In terms of safety, ADCs showed a trend toward fewer grade ≥3 Aes (OR = 0.68, p = 0.08), supporting their improved tolerability compared with conventional chemotherapy, and Diéras et al.

However, this distribution did not reach statistical significance, although it approached significance (p = 0.081).

189.9 pg/mL), approaching significance (p = 0.081), suggesting greater early inflammation in G2.